NeuroOne amends bylaws: reduces stockholder quorum to one-third, updates proxy rules

NEUROONE MEDICAL TECHNOLOGIES Corp

Stockholder quorum reduced from majority to one-third of outstanding voting power.
New universal proxy compliance requirement under SEC Rule 14a-19 for director nominations.
Enhanced disclosure obligations for stockholder nominations and proposals, including derivative interests.
Special meeting nominators must hold 10% of voting power and be stockholder at notice and record dates.
Clarified personal jurisdiction and service of process for foreign actions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.